Home page   News   Related Researches   2000-2009  
Title Created Date
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3 29 August 2014
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism 26 August 2014
Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer 25 August 2014
Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases 20 August 2014
Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer 20 August 2014
Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans 20 August 2014
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair 18 August 2014
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression 18 August 2014
Melatonin in pathogenesis and therapy of cancer 15 August 2014
Retinoid, retinoic acid receptor beta and breast cancer 15 August 2014
Display #